To examine the alteration of the plasma free-catecholamine level during hemopurification in a patient with pheochromocytoma, the levels of plasma free-catecholamine and total cate cholamine in the filtrate were monitored pre-and post-hemopurification. Approximately 100 /j,g of total catecholamine was removed by the hemopurification procedure though the high level of plasma-free catecholamine remained unaltered. (Internal Medicine 31: 438-440, 1992) 
Introduction
Pheochromocytoma is a disease which manifests a variety of clinical symptoms due to an excessive amount of endogenous catecholamines. The measurement of the catecholamine level in blood and urine is widely used for the diagnosis of pheochromocytoma. In hemo purification performed for pheochromocytoma, the mechanism by which the level of plasma catecholamine is modified remains unclear. To clarify this point, several parameters of catecholamine metabolites were quan titated in a patient with pheochromocytoma with anuresis before and after hemopurification. Case Report A forty-year-old male was admitted to the Endo crinology Department of Tokai University Hospital with the complaint of palpitation and headache. In the three previous years he was on hemodialysis three times a week due to chronic renal failure. One year previously, he noticed palpitation and pulsative headache when he lay on his left side. An annual abdominal echography revealed a right adrenal mass (5.0 x 3.5 cm in diameter). His height was 163.5cm and body weights was 52.0kg. His blood pressure was 146/92 under medication of prazosin hydrochloride 1.5mg per day. The physical examination showed no pathological findings in his chest and abdomen. The laboratory examination showed a remarkably high level of plasma free catecholamine, and the level of epinephrine was higher than the level of norepinephrine (Table 1) . Anemia and high levels of creatinine, urea N, inorganic phosphate and abnor mal glucose tolerance were also observed as the other abnormal findings. To monitor the catecholamine levels during the process of hemopurification, two different methods (Table 1) were employed: hemodialysis (HD) and hemofiltration (HF) (performed 3 times). The FB-150U (Nippon Ltd., Osaka, Japan) was used as the dialyzer and the F-60 (Fresenius AG, Bad Homburg) was used as the nTtlyzer. Plasma free-epinephrine and norepinephrine levels were determined pre-and post-hemopurification. In one pro cedure, the plasma free catecholamine level in the arterial sample and venous sample (drawn at the level of the shunt) was compared. The amount of epinephrine and norepinephrine in the filtrate was quantitated in the three hemofiltrations. As shown in Table 1, the plasma free catecholamine level following the hemofiltration was varied. After the first hemofiltration, a dramatic reduction of the plasma free catecholamine was ob served but this reduction was not seen in the following two hemofiltrations. The total amount of catecholamine in the filtrate was calculated to be 52.4-100.8pig for epinephrine and 21.6-62.0pig for norepinephrine. During and after the hemopurification, no alteration of blood pressure was observed and he had neither palpitation nor headache. The right adrenal mass was re-confirmed by scanning tomography and angiography. Right adrenalectomy and Table 1 . Catecholamine Levels during Hemopurification HP: hemopurification nephrectomy was performed on March 28. The resected adrenal tumor was 5cm X 5cm X 3.5cm in diameter and weighed 50 g. The histological findings were compatible with pheochromocytoma; the tumor was composed of large round or polygonal basophilic grandular cells. Immunohistochemically, positive staining was obtained against anti-phenylethanolamine N-methyl trans ferase. The amount of catecholamine in the tumor was 7,380.52 /ig/g wet tissue for epinephrine, 2,827.30/ig/g wet tissue for norepinephrine and 38.37 ^g/g wet tissue for dopamine. After removal of the pheochromocytoma, his blood pressure was lowered to the normal level and his head ache and palpitation disappeared; he was discharged from our hospital on April 9. He returned to his job and underwent routine hemodialysis. Discussion
In the present case of pheochromocytoma undergoing hemodialysis, catecholamine was quantitated in both the plasma and the filtrate. In the kinetics of catecholamine in normal man, the majority of the catecholamine in the blood is present as the sulfo-or glucuro-conjugated form following either extraneuronal or intraneuronal degradation. The conjugated catecholamines are secreted into the urine. Only 2-3% of the norepinephrine which enters circulation escapes metabolic degradation and is excreted unchanged into the urine (1). In contrast, the membrane used in hemopurification is able to filter the free catecholamine alone (2). Thus, the uniqueness of the present case is that the continuously overproduced endogenous catecholamine from the adrenal medulla remains in the blood for two days until free catecholamine is removed by hemopurification. Therefore, it would be of interest to determine the following two points: 1) the amount of catecholamine in the filtrate after one hemopurification procedure, and 2) the decrease in the plasma catecholamine level after hemopurification. Regarding the amount of cathecholamine in the di alysate, here it was quantitated to be approximately 77fig of epinephrine and 42fig of norepinephrine in one hemopurification procedure. In general, the daily amount of urinary excretion of catecholamine in common pheochromocytoma has been assessed to be approximately over 100fig (3). In the present case, hemodialysis was performed every two days, and the amount of catecholamine in the dialysate should be considered as the mass of two days. Therefore, the amount of catecholamine in the filtrate was calculated to be approximately half of that in the common pheo chromocytoma with normal kidney function. Regarding the second point, the hemopurification did not consistently result in a decrease in blood catecholamine. A decrease in plasma catecholamine was observed in only one of the three hemofiltrations. As hemopurification procedure was performed in a similar manner and the profile of the patient's blood pressure and pulse did not alter throughout the three hemopurification procedures. levels of plasma concentration dropped from 52 to 22pg/ml for epinephrine and from 400 to 165 pg/ml for norepinephrine, respectively. In agreement with the present data, the level of plasma catecholamine in the whole body circulation remained unaltered. Taken together, it can be assumed that the level of plasma free catecholamine does not alter following hemodialysis regardless of the elimination of catecholamine from the circulation. There are few possible explanations. First, the amount of catecholamine removed by the hemopurification was too small to lead to a reduction in the plasma catechol amine level in the whole body circulation. Secondly, the amount of endogenous free catecholamine production in the adrenergic tissue may have overcompensated for the amount removed into the filtrate. The free cate cholamine released from the conjugated catecholamine in blood may have possibly masked the reduction. To clarify these points, it will be necessary to design further experiments. Recently, two cases in addition to the present case of pheochromocytoma with anuresis have been reported (Table 2 ) (4, 5). The level of plasma norepinephrine was from 1,420 to 5,760pg/ml and the level of plasma epi nephrine was from 132 to 4,860pg/ml. These levels are similar to those of pheochromocytoma without hemo purification. The interesting point is that the finding of an abnormal adrenal mass on imaging examination pro ceeded the further detailed examination for the diagnosis of pheochromocytoma in these three cases.
In conclusion, in pheochromocytoma patients under hemodialysis, approximately 100pig of the total cate cholamine is removed into the dialysate hemopurification however this removal does not directly lead to a decrease in the plasma free catecholamine.
